Vote Scores

Home / Companies / IDEAYA Biosciences, Inc. / 24 Jun 2025

Meeting · year to 30 June 2025318 filers reporting

IDEAYA Biosciences, Inc.: meeting of 24 Jun 2025

Votes reported on Form N-PX, item by item

318 Form N-PX filers reported votes at the IDEAYA Biosciences, Inc. meeting of 24 Jun 2025. Their records fall into 3 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.

foragainstabstain, withhold or otheramber tick: the portion cast against management

Items

1

DIRECTOR ELECTIONSIssuer

Director elections

2 nominees; 56.4% of reported votes for; 71 filers withheld from or voted against at least one nominee.

358 vote records from 102 filers. 15 of the 102 filers that marked the item either way voted against management.

35.3% for0.0% against64.7% other14.7% against management102 filers
2

SECTION 14A SAY-ON-PAY VOTESIssuer

Advisory vote on executive pay (say-on-pay)

432 vote records from 317 filers. 106 of the 305 filers that marked the item either way voted against management. 12 filers reported this item without a management mark.

62.5% for32.8% against4.7% other34.8% against management317 filers79.1% for20.7% against0.2% other20.8% against management98,927,584 reported shares
3

AUDIT-RELATEDIssuer

Audit-related items (auditor ratification)

179 vote records from 102 filers. 3 of the 102 filers that marked the item either way voted against management.

97.1% for2.0% against1.0% other2.9% against management102 filers99.9% for0.0% against0.1% other0.1% against management35,803,278 reported shares

How the largest families voted

Family1. Directors2. Say-on-pay3. Auditor
VanguardForForFor
BlackRock and iSharesAbstain or withhold *Against *For
FidelityForForFor
DimensionalNo reportAgainst *No report
State Street and SPDRForForFor
American CenturySplit or no voteAgainst *For
InvescoSplit or no voteAgainst *For
EquitableAbstain or withhold *Against *For
Charles SchwabSplit or no voteAgainst *For
Nuveen and TIAAForForFor
ProShares and ProFundsSplit or no voteForFor
John Hancock and ManulifeForForFor
Morgan Stanley, Eaton Vance and CalvertAbstain or withhold *ForFor
J.P. MorganSplit or no voteForFor
Goldman SachsSplit or no voteForFor
PGIM and PrudentialAbstain or withhold *ForFor
Jackson National fundsForAgainst *For
Northern Trust and FlexSharesSplit or no voteForFor
SEISplit or no voteAgainst *For
T. Rowe PriceForForFor
Lincoln FinancialAbstain or withhold *ForFor
VoyaSplit or no voteForFor
First TrustNo reportForNo report
Russell InvestmentsNo reportAgainst *No report
NationwideAbstain or withhold *Against *For
Victory CapitalSplit or no voteForFor
Brighthouse FundsSplit or no voteForFor
Guggenheim and RydexSplit or no voteForFor
Columbia ThreadneedleForForFor
BNY MellonSplit or no voteForFor
PrincipalSplit or no voteForFor
Capital Group and American FundsForAgainst *For
Pacific Life fundsAbstain or withhold *Against *For
Global XSplit or no voteAgainst *For
Federated HermesSplit or no voteForFor
AllianceBernsteinNo reportForNo report
DWSSplit or no voteForFor
MassMutualForForFor
Janus HendersonForForFor
Neuberger BermanNo reportAgainst *No report
Natixis and Loomis SaylesNo reportAgainst *No report

* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.

Questions

How did large funds vote at the IDEAYA Biosciences, Inc. meeting?

318 Form N-PX filers reported votes at the meeting of 24 Jun 2025. On say-on-pay, 106 of 305 voted against management (34.8%). The family table lists each of the largest families item by item.

Is this the meeting result?

No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by IDEAYA Biosciences, Inc. on Form 8-K.

Why are director elections shown as counts only?

Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.

Every meeting on file for IDEAYA Biosciences, Inc.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing IDEAYA Biosciences, Inc. with a meeting date within three days of 24 Jun 2025. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.